Severe phenotype in patients with large deletions of NF1

Archive ouverte

Pacot, Laurence | Vidaud, Dominique | Sabbagh, Audrey | Laurendeau, Ingrid | Briand-Suleau, Audrey | Coustier, Audrey | Maillard, Theodora | Barbance, Cecile | Morice-Picard, Fanny | Sigaudy, Sabine | Glazunova, Olga O. | Damaj, Lena | Layet, Valerie | Quelin, Chloe | Gilbert-Dussardier, Brigitte | Audic, Frederique | Dollfus, Helene | Guerrot, Anne-Marie | Lespinasse, James | Julia, Sophie | Vantyghem, Marie-Christine | Drouard, Marie-Christine | Lackmy, Marylin | Leheup, Bruno | Alembik, Yves | Lemaire, Alexia | Nitschke, Patrick | Petit, Florence | Dieux Coeslier, Anne | Mutez, Eugenie | Taieb, Alain | Fradin, Melanie | Capri, Yline | Nasser, Hala | Ruaud, Lyse | Dauriat, Benjamin | Bourthoumieu, Sylvie | Genevieve, David | Audebert-Bellanger, Severine | Nizon, Mathilde | Stoeva, Radka | Hickman, Geoffroy | Nicolas, Gael | Mazereeuw-Hautier, Juliette | Jannic, Arnaud | Ferkal, Salah | Parfait, Beatrice | Vidaud, Michel | Wolkenstein, Pierre | Pasmant, Eric

Edité par CCSD ; MDPI -

International audience. Complete deletion of the NF1 gene is identified in 5–10% of patients with neurofibromatosis type 1 (NF1). Several studies have previously described particularly severe forms of the disease in NF1 patients with deletion of the NF1 locus, but comprehensive descriptions of large cohorts are still missing to fully characterize this contiguous gene syndrome. NF1-deleted patients were enrolled and phenotypically characterized with a standardized questionnaire between 2005 and 2020 from a large French NF1 cohort. Statistical analyses for main NF1-associated symptoms were performed versus an NF1 reference population. A deletion of the NF1 gene was detected in 4% (139/3479) of molecularly confirmed NF1 index cases. The median age of the group at clinical investigations was 21 years old. A comprehensive clinical assessment showed that 93% (116/126) of NF1-deleted patients fulfilled the NIH criteria for NF1. More than half had café-au-lait spots, skinfold freckling, Lisch nodules, neurofibromas, neurological abnormalities, and cognitive impairment or learning disabilities. Comparison with previously described “classic” NF1 cohorts showed a significantly higher proportion of symptomatic spinal neurofibromas, dysmorphism, learning disabilities, malignancies, and skeletal and cardiovascular abnormalities in the NF1-deleted group. We described the largest NF1-deleted cohort to date and clarified the more severe phenotype observed in these patients.

Suggestions

Du même auteur

PFMG2025–integrating genomic medicine into the national healthcare system in France

Archive ouverte | Abadie, Caroline | CCSD

International audience. Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patien...

One NF1 Mutation may Conceal Another

Archive ouverte | Pacot, Laurence | CCSD

International audience. Neurofibromatosis type 1 (NF1) is an autosomal dominant disease with complete penetrance but high variable expressivity. NF1 is caused by loss-of-function mutations in the NF1 gene, a negativ...

Modifier genes in NF1: results of the first Genome-Wide Association Study in 1,333 patients

Archive ouverte | Ferkal, Salah | CCSD

International audience

Chargement des enrichissements...